维普中文期刊产品整合服务
120篇 您的检索式:作者名="Cohen MC"
    题名 作者 年代 出处 被引量
1Denosumab治疗绝经后妇女低骨密度显示文摘Background: Receptor activator of nuclear factor- κ B ligand (RANKL) is essential for osteoclast differentiation, activation, and survival. The fully human monoclonal antibody denosumab (formerly known as AMG 162)- binds RANKL with high affinity and specificity and inhibits RANKL action. Methods: The efficacy and safety of subcutaneously administered denosumab were evaluated over a period of 12 months in 412 postmenopausal women with low bone mineral density (T score of- 1.8 to - 4.0 at the lumbar spine or- 1.8 to- 3.5 at the proximal femur). Subjects were randomly assigned to receive denosumab either every three months (at a dose of 6, 14, or 30 mg) or every six months (at a dose of 14, 60, 100, or 210 mg), open- label oral alendronate once weekly (at a dose of 70 mg), or placebo. The primary end point was the percentage change from baseline in bone mineral density at the lumbar spine at 12 months. Changes in bone turnover were assessed by measurement of serum and urine telopeptides and bone-specific alkaline phosphatase. Results: Denosumab treatment for 12 months resulted in an increase in bone mineral density at the lumbar spine of 3.0 to 6.7 percent (as compared with an increase of 4.6 percent with alendronate and a loss of 0.8 percent with placebo), at the total hip of 1.9 to 3.6 percent (as compared with an increase of 2.1 percent with alendronate and a loss of 0.6 percent with placebo), and at the distal third of the radius of 0.4 to 1.3 percent (as compared with decreases of 0.5 percent with alendronate and 2.0 percent with placebo). Near-maximal reductions in mean levels of serum C- telopeptide from baseline were evident three days after the administration of denosumab. The duration of the suppression of bone turnover appeared to be dose-dependent. Conclusions: In postmenopausal women with low bone mass, denosumab increased bone mineral density and decreased bone resorption. These preliminary data suggest that denosumab might be an effective treatment for osteoporosis.Mc Clung M.R. Michael Lewiecki E. Cohen S.B. 马超 2006世界核心医学期刊文摘(妇产科学分册)2006,0,8:19
2Two types of astrocytes incultures of development rat white matter: differences in morphology, surface gangliosides and growth characteristics显示文摘Raff MC Abney ER Cohen J 1983J Neurosci1983,3,:1
3The effect of low b-values on the intravoxel incoherent motionderived pseudodiffusion parameter in liver 显示文摘COHEN AD SCHIEKE MC HOHENWALTER MD 2015Magn ResonMed2015,73,1:1
4Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate显示文摘Genovese MC Cohen S Moreland L 2004Arthntis Rheum2004,50,5:1
5Effect of beta-blockade on circadian variation of ventricular arrhythmias显示文摘Cohen MC Rohtla KM Lavery EC 1997Am J Cardiol1997,79,11:1
6Cytokine function: a study in biologic diversity显示文摘Cohen MC Cohen S 1996Am J Clin Pathol1996,105,5:1
7Renal Cell carcinoma 显示文摘Cohen H Mc Govern F 2005N Eng J Med En2005,353,:1
8Cytokine function :a study in biologic diversity显示文摘 Cohen S 1996Clin Pathol1996,105,5:1
9Cytokine function: a study in biologic diversity显示文摘Cohen MC Cohen S 1996Am J Clin Pathol1996,105,5:1
10Complaints in forprofit,non-profit and public nursing homes in two Canadian provinces显示文摘Margaret J Mc Gregor Marcy Cohen Catherine-Rose 2011Open Med2011,5,4:1
11Biliary lipids and cholesterol gallstone disease显示文摘Wang DQ Cohen DE Carey MC 2009J Lipid Res2009,50,:1
12Meta - nalvsis of the morning excess of acute myocardial infarction and sudden cardiac death 显示文摘Cohen MC Rohtla KM Lavery CE 1997Am J Cardiol1997,79,:1
13Strategies to enhance participant recruitment and retention in research involving acommunity-based population显示文摘McCullagh MC Sanon MA Cohen MA 2014Applied Nursing Research2014,27,4:1
14Renal cell carcinoma显示文摘Cohen HT Mc Govern FJ 2005N Engl J Med2005,353,23:1
15Metastatic pulmonary calcification with ossification in a child with acute lymphoblastic leukemia显示文摘Cohen MC Drut R 1999Pediatr Pulmonol1999,27,2:1
16Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate显示文摘Cohen SB Keystone E Genovese MC 2010Ann Rheum Dis2010,69,6:1
17Impact of diabetes on long-term survival after acute myocardial infarction:comparability of risk with prior myocardial infarction显示文摘Mukamal KJ Nesto RW Cohen MC 2001Diabetes Care2001,24,8:1
18Interleukin - 10 rescues T cells from apoptotic cell death : association with upregulation of Bcl - 2 显示文摘Cohen SB Crawley JB Kahan MC 1997Immunology1997,92,1:1
19Factors Affecting Patient Selection of Graft Type in Anterior Cruciate Ligament Reconstruction显示文摘Cohen SB Yucha DT Ciccotti MC 2009The Journal of Arthroscopic&Related Surgery2009,25,9:1
20Pulmonary contusion:review of the clinical entity显示文摘Cohen MC 1997J Trauma1997,12,7:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费